Home/Filings/4/0001235645-04-000001
4//SEC Filing

MUELLER ALAN L 4

Accession 0001235645-04-000001

CIK 0000890465other

Filed

Jan 5, 7:00 PM ET

Accepted

Jan 6, 4:38 PM ET

Size

15.9 KB

Accession

0001235645-04-000001

Insider Transaction Report

Form 4
Period: 2004-01-02
MUELLER ALAN L
VP, Drug Discovery
Transactions
  • Gift

    Common Stock

    2004-01-02$31.36/sh1,920$60,2110 total
  • Exercise/Conversion

    Common Stock

    2004-01-02$10.75/sh+960$10,320960 total(indirect: By Spouse)
  • Tax Payment

    Common Stock

    2004-01-02$31.36/sh4,316$135,35010,200 total(indirect: By Trust)
  • Gift

    Common Stock

    2004-01-02$31.36/sh+15,270$478,86725,470 total(indirect: By Trust)
  • Exercise/Conversion

    Stock Option

    2004-01-02$4.50/sh3,600$16,2000 total
    Exercise: $4.50From: 2000-12-08Exp: 2009-12-08Common Stock (3,600 underlying)
  • Exercise/Conversion

    Common Stock

    2004-01-02$10.75/sh+9,750$104,8139,750 total
  • Exercise/Conversion

    Stock Option

    2004-01-02$10.75/sh9,750$104,8134,917 total
    Exercise: $10.75From: 2001-05-24Exp: 2010-05-24Common Stock (9,750 underlying)
  • Gift

    Common Stock

    2004-01-02$31.36/sh13,350$418,6560 total
  • Exercise/Conversion

    Common Stock

    2004-01-02$4.50/sh+3,600$16,20013,350 total
  • Exercise/Conversion

    Stock Option

    2004-01-02$4.50/sh960$4,3200 total(indirect: By Spouse)
    Exercise: $4.50From: 2000-12-08Exp: 2009-12-08Common Stock (960 underlying)

Issuer

NPS PHARMACEUTICALS INC

CIK 0000890465

Entity typeother

Related Parties

1
  • filerCIK 0001235645

Filing Metadata

Form type
4
Filed
Jan 5, 7:00 PM ET
Accepted
Jan 6, 4:38 PM ET
Size
15.9 KB